The rapid identification of respiratory virus outbreaks is needed to enable rational and effective public health interventions. We developed new quantitative approaches for simultaneous ...

"Based on insights from six in-depth reports, this review explores how breakthroughs in sequencing, RNAi, and viral vector technologies will shape the future of biotech through 2029.”Boston, July 07, ...

No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.

Linked to neurological disorders, repeat RNAs aggregate inside droplets but can be disassembled with an engineered piece of ...

Thermo Fisher Scientific, the world leader in serving science, today announced the U.S. Food and Drug Administration (FDA) ...

Genome editing technologies like CRISPR-Cas9 have transformed biology, medicine, and agriculture, but concerns remain about unintended edits at off-target DNA sites. These off-target effects can cause ...

Global Antisense and RNAi therapeutics Market is valued approximately at USD 3.69 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 18.72% over the forecast period ...

In today’s digitally driven world, advanced security for online transactions and communications is more crucial than ever. This paper introduces a groundbreaking digital signature authentication ...

A new gene therapy delivery device could let hospital pharmacies make personalized nanomedicines to order. This democratized approach to precision medicine, as published in Frontiers in Science, could ...

Correction for Smith et al., A twist grain boundary phase in aqueous solutions of the nucleic acid tetramer GTAC ...

Nucleic acids, with their programmability and predictability rooted in sequence-specific hybridization, have emerged as exceptional functional materials for constructing nanoscale molecular tools with ...